SCR Pyme
Calle Bendición de Campos, 3, Barcelona, Catalonia, Spain
Overview
VICTORIA Venture Capital invests in spin-offs, providing equity from private investors and business advice. The company invests in the capital of spin-offs, which are new companies with cutting-edge technologies that emerge from Research Centers and Universities. The main sectors are cleantech and new advanced materials for Industry. VICTORIA provides business advice, financial and corporate support to the founders of spin-offs, adding value to boost growth of these companies.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 2
Sector focus
- Advice
- Finance
- Financial Services
Investment portfolio
- Bioherent
Participated · Equity · May 2026
Bioherent, founded in 2021 as a University of Málaga spin-off, develops miniaturized integrated photonic sensors combined with surface chemistry and advanced nanomaterials to create label-free biosensors for clinical diagnostics. Its core product is the AllerWAVE system, a compact desktop analyzer with disposable cartridges designed for rapid detection of allergies to antibiotics and acute drug reactions used in anesthesia and biological therapies. The company's technology aims to deliver faster, simplified and highly precise analyses without sending samples to external labs, reducing reliance on highly specialized personnel. Bioherent is supported by three university research groups in photonics, chemistry and medicine and has positioned AllerWAVE to address misdiagnoses of antibiotic allergies and associated antimicrobial resistance issues. In July 2025 it raised €2 million in a financing round involving Axon Partners, the CDTI (Innvierte) and Bullnet Capital, and in March it secured an additional €284,000 in a CDTI-led coinvestment to further develop its diagnostic systems.